Pathological gambling: A systematic review of biochemical, neuroimaging, and neuropsychological findings

Harvard Review of Psychiatry

Volumn 20, Issue 3, 2012, Pages 130-148

  Conversano, Ciro ^a   Marazziti, Donatella ^a   Carmassi, Claudia ^a   Baldini, Sara ^b   Barnabei, Graziano ^c   Dell'Osso, Liliana ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CNR   (Italy)

^c CSDC   (Italy)

Author keywords

biochemistry; neuroimaging; neuropsychology; pathological gambling

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; AMFEBUTAMONE; CLOMIPRAMINE; CLONIDINE; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; HYDROCORTISONE; KAPPA OPIATE RECEPTOR; LITHIUM; MEMANTINE; MU OPIATE RECEPTOR; NALMEFENE; NALTREXONE; NORADRENALIN; PAROXETINE; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SEROTONIN; VALPROIC ACID;

AGGRESSION; ANTERIOR CINGULATE; ANXIETY; APPETITE; BASOLATERAL AMYGDALA; BIOCHEMISTRY; BOLD SIGNAL; CELLULAR STRESS RESPONSE; CEREBROSPINAL FLUID; COGNITION; COMMUNICATION SKILL; COMORBIDITY; DECISION MAKING; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; EMOTION; EXECUTIVE FUNCTION; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEART RATE; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMPULSIVENESS; INFERIOR FRONTAL GYRUS; LEARNING; MENTAL FUNCTION; MESOLIMBIC DOPAMINERGIC SYSTEM; MIDDLE FRONTAL GYRUS; MOOD; MOTIVATION; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEUS ACCUMBENS; OCCIPITAL CORTEX; OCCIPITAL LOBE; ORBITAL CORTEX; PARAHIPPOCAMPAL GYRUS; PARAVENTRICULAR THALAMIC NUCLEUS; PARIETAL LOBE; PATHOLOGICAL GAMBLING; PLANNING; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; RESPONSE INHIBITION; REVIEW; SIMULATION; SUICIDE; TASK PERFORMANCE; VENTRAL TEGMENTUM; VERBAL COMMUNICATION; WORKING MEMORY;

AROUSAL; BRAIN; BRAIN MAPPING; EXECUTIVE FUNCTION; GAMBLING; HUMANS; INHIBITION (PSYCHOLOGY); MAGNETIC RESONANCE IMAGING; MOTIVATION; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; NEUROTRANSMITTER AGENTS; RISK-TAKING;

EID: 84862878285     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.3109/10673229.2012.694318     Document Type: Review

References (249)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: APA, 1980.
2. Lesieur HR. The chase: career of the compulsive gambler. Rochester, VT: Schenkman, 1984.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed., rev. Washington, DC: APA, 1987.
4. Rosenthal RJ. Pathological gambling and problem gambling: problems of definition and diagnosis. In: Shaffer HJ, Stein SA, GambinoG, Cummings TN, eds. Compulsive gambling: theory, research, and practice. Lexington, MA: Lexington, 1989.
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text revision. Washington, DC: APA, 2000.
6. Blum K, Braverman ER, Holder JM, et al. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs 2000;32 suppl:i-iv, 1-112.
7. Koob GF, LeMoalM. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001;24:97-129.
8. Blaszczynski A, Nower L. A pathways model of problem and pathological gambling. Addiction 2002;97:487-99. (Pubitemid 34492743)
9. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002;159: 1642-52.
10. Sharpe L. A reformulated cognitive-behavioral model of problem gambling. A biopsychosocial perspective. Clin Psychol Rev 2002;22:1-25. (Pubitemid 33109011)
11. Shenassa ED, Paradis AD, Dolan SL, Wilhelm CS, Buka SL. Childhood impulsive behavior and problem gambling by adulthood: a 30-year prospective community-based study. Addiction 2012;107:160-8.
12. Carragher N, McWilliams LA. A latent class analysis of DSMIV criteria for pathological gambling: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychiatry Res 2011;187:185-92.
13. Felicity K, Lorains FK, Cowlishaw S, Thomas SA. Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta-analysis of population surveys. Addiction 2011;106:490-8.
14. Shaffer HJ, Hall MN. Updating and refining prevalence estimates of disordered gambling behaviour in the United States and Canada. Can J Public Health 2001;92:168-72. (Pubitemid 32821451)
15. Shaffer HJ, Hall MN, Vander Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health 1999;89:1369-76. (Pubitemid 29404561)
16. Gerstein DR, Volberg RA, Toce MT, et al. Gambling impact and behavior study. Report to the National Gambling Impact Study Commission. Chicago, IL: National Opinion Research Center, 1999.
17. Blinn-Pike L, Worthy SL, Jonkman JN. Adolescent gambling: a review of an emerging field of research. J Adolesc Health 2010;47:223-36.
18. Pietrzak RH, Ladd GT, Petry NM. Disordered gambling in adolescents: epidemiology, diagnosis, and treatment. Paediatr Drugs 2003;5:583-95. (Pubitemid 37159614)
19. Lynch WJ, Maciejewski PK, Potenza MN. Psychiatric correlates of gambling in adolescents and young adults grouped by age at gambling onset. Arch Gen Psychiatry 2004;61: 1116-22. (Pubitemid 39463413)
20. Potenza MN, Wareham JD, Steinberg MA, et al. Correlates of at-risk/problem Internet gambling in adolescents. J Am Acad Child Adolesc Psychiatry 2011;50:150-9.
21. Pedrelli P, Bitran S, Shyu I, et al. Compulsive alcohol use and other high-risk behaviors among college students. Am J Addict 2011;20:14-20.
22. Volberg RA. The prevalence and demographics of pathological gamblers: implications for public health. Am J Public Health 1994;84:237-41. (Pubitemid 24138458)
23. Volberg RA, Abbott MW, Ronnberg S, Munck IM. Prevalence and risks of pathological gambling in Sweden. Acta Psychiatr Scand 2001;104:250-6. (Pubitemid 32906970)
24. Lorains FK, Cowlishaw S, Thomas SA. Prevalence of comorbid disorders in problem and pathological gambling: systematic review andmeta-analysis of population surveys. Addiction 2011;106:490-8.
25. Chou KL, Afifi TO. Disordered (pathologic or problem) gambling and Axis I psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Am J Epidemiol 2011;173:1289-97.
26. Kennedy SH, Welsh BR, Fulton K, et al. Frequency and correlates of gambling problems in outpatients with major depressive disorder and bipolar disorder. Can J Psychiatry 2010;55:568-76.
27. Barnes GM, Welte JW, Hoffman JH, Tidwell MC. The cooccurrence of gambling with substance use and conduct disorder among youth in the United States. Am J Addict 2011;20:166-73.
28. Bowden-Jones H, Clark L. Pathological gambling: a neurobiological and clinical update. Br J Psychiatry 2011;199:87-9.
29. Barnes GM, Welte JW, Hoffman JH, Tidwell MC. The cooccurrence of gambling with substance use and conduct disorder among youth in the United States. Am J Addict 2011;20:166-73.
30. Leeman RF, Potenza MN. Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology (Berl) 2012;219:469-90.
31. Wareham JD, Potenza MN. Pathological gambling and substance use disorders. Am J Drug Alcohol Abuse 2010;36: 242-7.
32. Presta S, Marazziti D, Dell'Osso L, Pfanner C, Pallanti S, Cassano GB. Kleptomania: clinical features and comorbidity in an Italian sample. Compr Psychiatry 2002;43:7-12. (Pubitemid 34056269)
33. Lobo DS, Kennedy JL. Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities. Addiction 2009;104:1454-65.
34. Greck M, Enzi B, Prösch U, Gantman A, Tempelmann C, Northoff G. Decreased neuronal activity in reward circuitry of pathological gamblers during processing of personal relevant stimuli. Hum Brain Mapp 2010;31:1802-12.
35. van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE. Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. Neurosci Biobehav Rev 2010;34:87-107.
36. Linnet J,Møller A, Peterson E, Gjedde A, Doudet D. Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling. Addiction 2011;106:383-90.
37. Linnet J, Møller A, Peterson E, Gjedde A, Doudet D. Inverse association between dopaminergic neurotransmission and Iowa Gambling Task performance in pathological gamblers and healthy controls. Scand J Psychol 2011;52:28-34.
38. Nussbaum D, Honarmand K, Govoni R, et al. An eight component decision-making model for problem gambling: a systems approach to stimulate integrative research. J Gambl Stud 2011;27:523-63.
39. Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics 1995;5:121-41.
40. Comings DE, Rosenthal RJ, Lesieur HR, et al. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 1996;6:223-34. (Pubitemid 26226314)
41. Perez de Castro I, Torres P, Saiz-Ruiz J, Fernandez-Piqueras J. Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene. Pharmacogenetics 1997;7:345-8. (Pubitemid 27427542)
42. Comings DE, Gonzalez N, Wu S, Gade R, Muhleman D, et al. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am J Med Genet 1999;88:358-68. (Pubitemid 29372249)
43. Bergh C, Eklund T, Sodersten P, Nordin C. Altered dopamine function in pathological gambling. Psychol Med 1997;27:473-5. (Pubitemid 27139979)
44. Meyer G, Schwertfeger J, Exton MS, et al. Neuroendocrine response to casino gambling in problem gamblers. Psychoneuroendocrinology 2004;29:1272-80. (Pubitemid 39024352)
45. Shinohara K, Yanagisawa A, Kagota Y, et al. Physiological changes in Pachinko players; beta-endorphin, catecholamines, immune system substances and heart rate. Appl Human Sci 1999;18:37-42.
46. Weintraub D, Potenza MN. Impulse control disorders in Parkinson's disease. Curr Neurol Neurosci Rep 2006;6:302-6. (Pubitemid 44069969)
47. Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 2003;61:422-3. (Pubitemid 36975988)
48. Ambermoon P, Carter A, Hall WD, Dissanayaka NN, O'Sullivan JD. Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction 2011;106:283-93.
49. Claassen DO, van den Wildenberg WP, Ridderinkhof KR, et al. The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Behav Neurosci 2011;125:492-500.
50. Gescheidt T, Bares M. Impulse control disorders in patients with Parkinson's disease. Acta Neurol Belg 2011;111:3-9.
51. Voon V, Gao J, Brezing C, et al. Dopamine agonists and risk: impulse control disorders in Parkinson's disease. Brain 2011;134:1438-46.
52. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006;63:969-73. (Pubitemid 44036299)
53. Voon V, HassanK, ZurowskiM, et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 2006;66:1750-2. (Pubitemid 43964638)
54. Siever L, Trestman RL. The serotonin system and aggressive personality disorder. Int Clin Psychopharmacol 1993;8 suppl 2:33-9. (Pubitemid 24063805)
55. Clark L, Roiser JP, Cools R, Rubinsztein DC, Sahakian BJ, Robbins TW. Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology (Berl) 2005;182:570-8. (Pubitemid 41464639)
56. Ryding E, Ahnlide JA, Lindstrom M, Rosen I, Traskman-Bendz L. Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy. Psychiatry Res 2006;148:195-203. (Pubitemid 44750588)
57. Carrasco JL, Saiz-Ruiz J, Hollander E, Cesar J, Lopez-Ibor JJ Jr. Low platelet monoamine oxidase activity in pathological gambling. Acta Psychiatr Scand 1994;90:427-31. (Pubitemid 24358503)
58. Blanco C, Orensanz-Munoz L, Blanco-Jerez C, Saiz-Ruiz J. Pathological gambling and platelet MAO activity: a psychobiological study. Am J Psychiatry 1996;153:119-21. (Pubitemid 26026170)
59. DeCaria C, Begaz T, Hollander E. Serotonergic and noradrenergic function in pathological gambling. CNS Spectr 1998;3:38-47. (Pubitemid 29124619)
60. Pallanti S, Bernardi S, Quercioli L, DeCaria C, Hollander E. Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo. CNS Spectr 2006;11:956-64. (Pubitemid 46025641)
61. Zohar J, Insel TR. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biol Psychiatry 1987;22:667-87. (Pubitemid 17101476)
62. Pallanti S, Bernardi S, Allen A, Hollander E. Serotonin function in pathological gambling: blunted growth hormone response to sumatriptan. J Psychopharmacol 2010;24: 1802-9.
63. Nordin C, Sjodin I. CSF monoamine patterns in pathological gamblers and healthy controls. J PsychiatrRes 2006;40:454-9. (Pubitemid 43816584)
64. Roy A, Adinoff B, Roehrich L, et al. Pathological gambling. A psychobiological study. Arch Gen Psychiatry 1988;45:369-73.
65. Uebelhack R, Franke L, Herold N, Plotkin M, Amthauer H, Felix R. Brain and platelet serotonin transporter in humans-correlation between [123I]-ADAM SPECT and serotonergic measurements in platelets. Neurosci Lett 2006;406:153-8. (Pubitemid 44376570)
66. Rudnick G. Serotonin transporters-structure and function. J Membr Biol 2006;213:101-10.
67. Marazziti D, Akiskal HS, Rossi A, Cassano GB. Alteration of the platelet serotonin transporter in romantic love. Psychol Med 1999;29:741-5. (Pubitemid 29261363)
68. Marazziti D, Rucci P, Di Nasso E, et al. Jealousy and subthreshold psychopathology: a serotonergic link. Neuropsychobiology 2003;47:12-6. (Pubitemid 36469780)
69. Lesch KP. Linking emotion to the social brain. The role of the serotonin transporter in human social behaviour. EMBO Rep 2007;8 Spec No:S24-9. (Pubitemid 47335493)
70. Serretti A, Calati R,Mandelli L, De Ronchi D. Serotonin transporter gene variants and behavior: a comprehensive review. Curr Drug Targets 2006;7:1659-69. (Pubitemid 44873728)
71. Moreno I S-RJ, Lopez-Ibor J. Serotonin and gambling dependence. Hum Psychopharmacol 1991;6(suppl):9-12.
72. Rotondo A, Giannaccini G, Betti L, et al. The serotonin transporter from human brain: purification and partial characterization. Neurochem Int 1996;28:299-307. (Pubitemid 26063021)
73. Marazziti D, Golia F, Picchetti M, et al. Decreased density of the platelet serotonin transporter in pathological gamblers. Neuropsychobiology 2008;57:38-43. (Pubitemid 351859332)
74. Pallanti S, Bernardi S, Allen A, et al. Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine. J Psychopharmacol 2010;24:847-53.
75. Johnson SW, North RA. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 1992;12:483-8.
76. Margolis EB, Hjelmstad GO, Bonci A, Fields HL. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J Neurosci 2003;23:9981-6. (Pubitemid 37392543)
77. Ford CP, Mark GP, Williams JT. Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci 2006;26:2788-97. (Pubitemid 43357862)
78. Kreek MJ, Nielsen DA, Butelman ER, LaForge KS. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 2005;8:1450-7. (Pubitemid 41573655)
79. Grant JE, Brewer JA, Potenza MN. The neurobiology of substance and behavioral addictions. CNSSpectr 2006;11:924-30. (Pubitemid 46025638)
80. Krueger TH, SchedlowskiM,Meyer G. Cortisol and heart rate measures during casino gambling in relation to impulsivity. Neuropsychobiology 2005;52:206-11. (Pubitemid 41677020)
81. Paris JJ, Franco C, Sodano R, Frye CA, Wulfert E. Gambling pathology is associated with dampened cortisol response among men and women. Physiol Behav 2010;99:230-3.
82. Potenza MN. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos Trans R Soc Lond B Biol Sci 2008;363:3181-9.
83. van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE. Brain imaging studies in pathological gambling. Curr Psychiatry Rep 2010;12:418-25.
84. Breiter HC, Aharon I, Kahneman D, Dale A, Shizgal P. Functional imaging of neural responses to expectancy and experience of monetary gains and losses. Neuron 2001;30: 619-39. (Pubitemid 32530601)
85. Elliott R, Friston KJ, Dolan RJ. Dissociable neural responses in human reward systems. J Neurosci 2000;20:6159-65. (Pubitemid 30658409)
86. Elliott R, Newman JL, Longe OA, Deakin JF. Differential response patterns in the striatum and orbitofrontal cortex to financial reward in humans: a parametric functional magnetic resonance imaging study. J Neurosci 2003;23:303-7. (Pubitemid 36050431)
87. O'Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat Neurosci 2001;4:95-102. (Pubitemid 32095532)
88. Kalivas PW. Drug addiction: to the cortex and beyond! Am J Psychiatry 2001;158:349-50.
89. Spanagel R,Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci 1999;22:521-7. (Pubitemid 29481853)
90. Zink CF, Pagnoni G, Martin-Skurski ME, Chappelow JC, Berns GS. Human striatal responses to monetary reward depend on saliency. Neuron 2004;42:509-17. (Pubitemid 38610148)
91. Hikosaka K, Watanabe M. Delay activity of orbital and lateral prefrontal neurons of the monkey varying with different rewards. Cereb Cortex 2000;10:263-71. (Pubitemid 30159293)
92. Mesulam MM. The human frontal lobes: transcending the default mode through contingent encoding. In: Stuss DT, Knight RT, eds. Principles of frontal lobe function. New York: Oxford University Press, 2002.
93. Chase HW, Clark L, Sahakian BJ, Bullmore ET, Robbins TW. Dissociable roles of prefrontal subregions in self-ordered working memory performance. Neuropsychologia 2008;46: 2650-61.
94. Corbetta M, Shulman GL. Control of goal-directed and stimulus-driven attention in the brain. Neuroscience 2002; 3:201-15. (Pubitemid 135706590)
95. Ramnani N, Miall RC. Instructed delay activity in the human prefrontal cortex is modulated by monetary reward expectation. Cereb Cortex 2003;13:318-27. (Pubitemid 36236678)
96. Heinz A, Siessmeier T, Wrase J, et al. Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry 2004;161:1783-9. (Pubitemid 39314671)
97. Maas LC, Lukas SE, Kaufman MJ, et al. Functional magnetic resonance imaging of human brain activation during cure-induced cocaine craving. Am J Psychiatry 1998;155: 124-6. (Pubitemid 28037560)
98. Volkow ND, Wang GJ, Ma Y, et al. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 2003;23:11461-8. (Pubitemid 37549703)
99. Wexler BE, Gottschalk CH, RK, Fulbright I, et al. Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 2001;158:86-95. (Pubitemid 32047251)
100. Potenza MN, Steinberg MA, Skudlarski P, et al. Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry 2003;60: 828-36. (Pubitemid 36960914)
101. PotenzaMN, Leung HC, Blumberg HP, et al. An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry 2003;160:1990-4. (Pubitemid 39619636)
102. Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005;8:147-8. (Pubitemid 40194043)
103. Bechara A, Damasio H, Tranel D, Damasio AR. Deciding advantageously before knowing the advantageous strategy. Science 1997;275:1293-5. (Pubitemid 27114154)
104. Bechara A, Damasio H, Tranel D, Anderson SW. Dissociation of working memory from decision making within the human prefrontal cortex. J Neurosci 1998;18:428-37. (Pubitemid 28046800)
105. de Ruiter MB, Veltman DJ, Goudriaan AE, Oosterlaan J, Sjoerds Z, van den Brink W. Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers. Neuropsychopharmacology 2009;34:1027-38.
106. Hommer DW, Bjork JM, Knitson B, Caggiano D, Fong G, Danube C. Motivation in children of alcoholics. Alcohol Clin Exp Res 2004;28:22A.
107. Pearlson GD, Shashwath M, Andre T, et al. Abnormal fMRI activation of reward circuitry in current versus former cocaine abusers. Presented at theAmerican College of Neuropsychopharmacology annual conference, Boca Raton, FL, December 2007.
108. CrockfordDN, Goodyear B, Edwards J,Quickfall J, el-Guebaly N. Cue-induced brain activity in pathological gamblers. Biol Psychiatry 2005;58:787-95. (Pubitemid 41677417)
109. Goudriaan AE, de Ruiter MB, van den Brink W, Oosterlaan J, Veltman DJ. Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. Addict Biol 2010;15:491-503.
110. Miedl SF, Fehr T, Meyer G, Herrmann M. Neurobiological correlates of problem gambling in a quasi-realistic blackjack scenario as revealed by fMRI. Psychiatry Res 2010;181: 165-73.
111. Dannon PN, Kushnir T, Aizer A, Gross-Isseroff R, Kotler M, Manor D. Alternation learning in pathological gamblers: an fMRI study. Brain Imaging Behav 2011;25:45-51.
112. Ko CH, Liu GC, Hsiao S, et al. Brain activities associated with gaming urge of online gaming addiction. J Psychiatr Res 2009;43:739-47.
113. Logan GD, CowanWB, Davis KA. On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 1984;10:276-91.
114. Bachorowski JA, Newman JP. Impulsive motor behavior: effects of personality and goal salience. J Pers Soc Psychol 1990;58:512-8.
115. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-62.
116. Golden CJ. Identification of brain disorders by the Stroop Color and Word Test. J Clin Psychol 1976;32:654-8.
117. Grant DA, Berg EA. A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem. J Exp Psychol 1948;38: 404-11.
118. Heaton RK. A manual for the Wisconsin Card Sorting Test. Odessa, FL: Psychological Assessment Sources, 1981.
119. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsycholgical Test Battery: therapy and clinical interpretation. Tucson, AZ: Neuropsychological, 1985.
120. Benton AL. Problems of test construction in the field of aphasia. Cortex 1967;3:32-58.
121. Benton AL, Hamsher K, Sivan AB. Multilingual aphasia examination. Iowa City, IA: AJA Associates, 1976.
122. Isaacs B, Kennie I. The set test: an aid to the detection of dementia in old people. Br J Psychiatry 1973;123:467-70.
123. Shallice T. Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci 1982;298:199-209.
124. Reitan RM. The relation of the trail making test to organic brain damage. J Consult Psychol 1955;19:393-4.
125. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994;50:7-15.
126. Green L, Fry AF, Myerson J. Discounting of delayed rewards: the role of age and income. Psychol Aging 1994;11:79-84. (Pubitemid 26133405)
127. Kirby KN, Petry NM, Bickel WK. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen 1999;128:78-87.
128. Newman JP, Widom CS, Nathan S. Passive avoidance in syndromes of disinhibition: psychopathy and extraversion. J Pers Soc Psychol 1985;48:1316-27.
129. Newman JP, Patterson CM, Kosson DS. Response perseveration in psychopaths. J Abnorm Psychol 1987;96:145-8. (Pubitemid 17085621)
130. Roberts AC. Introduction. In: Roberts AC, Robbins TW, Weiskrantz L, eds. The prefrontal cortex: executive and cognitive functions. Oxford: Oxford University Press, 1998.
131. Miyake A, Shah P. Toward unified theories of working memory: emerging general consensus, unresolved theoretical issues, and future research directions. In: Miyake A, Shah P, eds. Models of working memory: mechanisms of active maintenance and executive control. Cambridge: Cambridge University Press, 1999.
132. Baddeley A, Hitch G. Working memory. In: Bower GH, ed. Recent advances in learning and motivation. New York: Academic, 1974.
133. Lezak MD. Neuropsychological assessment. 2nd ed. New York: Oxford University Press, 1983.
134. Luria AR. The working brain: an introduction to neuropsychology. New York: Basic, 1973.
135. Stuss DT, Benson DF. The frontal lobes. New York: Raven, 1986.
136. Baddeley A, Wilson B. Frontal amnesia and the dysexecutive syndrome. Brain Cogn 1988;7:212-30.
137. Ardila A, Surloff C. Dysexecutive syndromes. In: Medlink neurology. San Diego, CA: Arbor, 2004.
138. Norris G, Tate R. The Behavioral Assessment of the Dysexecutive Syndrome (BADS): ecological, concurrent and construct validity. Neuropsychol Rehabil 2000;11:33-45. (Pubitemid 30088790)
139. Hobson P, Leeds L. Executive functioning in older people. Rev Clin Gerontol 2001;11:361-72. (Pubitemid 34614957)
140. Koechlin E, Corrado G, Pietrini P, Grafman J. Dissociating the role of the medial and lateral anterior prefrontal cortex in human planning. Proc Natl Acad Sci U S A 2000;97:7651-6. (Pubitemid 30431518)
141. Stuss DT, Alexander MP. Affectively burnt in one role of the right frontal lobe? In: Tulving E, ed. Memory, consciousness, and the brain: the Tallinn conference. Philadelphia: Psychology, 2000.
142. Stuss DT, Alexander MP, Floden D, et al. Fractionation and localization of distinct frontal lobe processes: evidence from focal lesions in humans. In: Stuss DT, Knight RT, eds. Principles of frontal lobe function. New York: Oxford University Press, 2002.
143. Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM. Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. Eur J Neurosci 2004;19:755-60. (Pubitemid 38241314)
144. Monchi O, Petrides M, Strafella AP, Worsley KJ, Doyon J. Functional role of the basal ganglia in the planning and execution of actions. Ann Neurol 2006;59:257-64. (Pubitemid 43202478)
145. Kassubek J, Juengling FD, Ecker D, Landwehrmeyer GB. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis. Cereb Cortex 2005;15:846-53. (Pubitemid 40696123)
146. Stuss DT, Benson D F. The frontal lobes. New York: Raven, 1986.
147. Cummings JL. Anatomic and behavioral aspects of frontal-subcortical circuits. Ann N Y Acad Sci 1995;769:1-13. (Pubitemid 26075880)
148. Duke LM, Kaszniak AW. Executive control functions in degenerative dementias: a comparative review. Neuropsychol Rev 2000;10:75-99. (Pubitemid 30480340)
149. Milner B. Interhemispheric differences in the localization of psychological processes in man. Br Med Bull 1971;27:272-7.
150. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993;50:873-80. (Pubitemid 23229317)
151. Jonides J, Smith EE, Koeppe RA, Awh E, Minoshima S, Mintun MA. Spatial working memory in humans as revealed by PET. Nature 1993;363:623-5. (Pubitemid 23227621)
152. Grafman J, Litvan I. Importance of deficits in executive functions. Lancet 1999;354:1921-3.
153. Salloway SP, Malloy PF, Duffy JD, eds. The frontal lobes and neuropsychiatric illness. Washington, DC: American Psychiatric Publishing, 2011.
154. Fellows LK. The role of orbifrontal cortex in decision-making: a component process account. Ann N Y Acad Sci 2007;1121:421-30.
155. Perry JL, Joseph JE, Jiang Y, et al. Prefrontal cortex and drug abuse vulnerability: translation to prevention and treatment interventions. Brain Res Rev 2011;65:124-49.
156. Bechara A, Tranel D, Damasio H. Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. Brain 2000;123:2189-202.
157. Clark L, Bechara A, Damasio H, Aitken MR, Sahakian BJ, Robbins TW. Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain 2008;131:1311-22.
158. Sugrue LP, Corrado GS, Newsome WT. Choosing the greater of two goods: neural currencies for valuation and decision making. Nat Rev Neurosci 2005;6:363-75. (Pubitemid 40593482)
159. Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction 2006;101:534-47. (Pubitemid 43375617)
160. Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Psychophysiological determinants and concomitants of deficient decision making in pathological gamblers. Drug Alcohol Depend 2006;84:231-9. (Pubitemid 44287212)
161. Goudriaan AE, Oosterlaan J, De Beurs E, Van Den Brink W. The role of self-reported impulsivity and reward sensitivity versus neurocognitive measures of disinhibition and decision-making in the prediction of relapse in pathological gamblers. Psychol Med 2008;38:41-50. (Pubitemid 350275203)
162. Regard M, Knoch D, Gutling E, Landis T. Brain damage and addictive behavior: a neuropsychological and electroencephalogram investigation with pathologic gamblers. Cogn Behav Neurol 2003;16:47-53. (Pubitemid 37254443)
163. Kertzman S, Lowengrub K, Aizer A, Nahum ZB, Kotler M, et al. Stroop performance in pathological gamblers. Psychiatry Res 2006;142:1-10. (Pubitemid 43775796)
164. Kalechstein AD, Fong T, Rosenthal RJ, Davis A, Vanyo H, Newton TF. Pathological gamblers demonstrate frontal lobe impairment consistent with that of methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci 2007;19:298-303. (Pubitemid 47293903)
165. Canas J, Quesada JF, Antoli A, Fajardo I. Cognitive flexibility and adaptability to environmental changes in dynamic complex problem-solving tasks. Ergonomics 2003;46: 482-501. (Pubitemid 36581960)
166. Payne JW, Bettman JR, Johnson EJ. The adaptive decision maker. Cambridge: Cambridge University Press, 1993.
167. Rugle L, Melamed L. Neuropsychological assessment of attention problems in pathological gamblers. J Nerv Ment Dis 1993;181:107-12. (Pubitemid 23090160)
168. Cavedini P, Riboldi G, Keller R, D'Annucci A, Bellodi L. Frontal lobe dysfunction in pathological gambling patients. Biol Psychiatry 2002;51:334-41. (Pubitemid 34214999)
169. Forbush KT, Shaw M, Graeber MA, et al. Neuropsychological characteristics and personality traits in pathological gambling. CNS Spectr 2008;13:306-15. (Pubitemid 351656252)
170. Marazziti D, Catena Dell'Osso M, Conversano C, et al. Executive function abnormalities in pathological gamblers. Clin Pract Epidemiol Ment Health 2008;4:7.
171. Anderson SW, Damasio H, Jones RD, Tranel D. Wisconsin Card Sorting Test performance as a measure of frontal lobe damage. J Clin Exp Neuropsychol 1991;13: 909-22.
172. Berman KF, Ostrem JL, Randolph C, et al. Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. Neuropsychologia 1995;33:1027-46.
173. Mentzel HJ, Gaser C, Volz HP, et al. Cognitive stimulation with the Wisconsin Card Sorting Test: functional MR imaging at 1.5 T. Radiology 1998;207:399-404. (Pubitemid 28259055)
174. Nagahama Y, Fukuyama H, Yamauchi H, et al. Cerebral activation during performance of a card sorting test. Brain 1996;119:1667-75. (Pubitemid 26375735)
175. Brand M, Kalbe E, Labudda K, Fujiwara E, Kessler J, Markowitsch HJ. Decision-making impairments in patients with pathological gambling. Psychiatry Res 2005;133:91-9. (Pubitemid 40215475)
176. Barry D, Petry NM. Predictors of decision-making on the Iowa Gambling Task: independent effects of lifetime history of substance use disorders and performance on the Trail Making Test. Brain Cogn 2008;66:243-52. (Pubitemid 351296370)
177. Stuss DT, Bisschop SM, Alexander MP, Levine B, Katz D, Izukawa D. The Trail Making Test: a study in focal lesion patients. Psychol Assess 2001;13:230-9. (Pubitemid 32552945)
178. Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002;53:647-54. (Pubitemid 36292444)
179. Fellows LK, Farah MJ. Different underlying impairments in decision-making following ventromedial and dorsolateral frontal lobe damage in humans. Cereb Cortex 2005;15: 58-63. (Pubitemid 40019052)
180. Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW. Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 1990;28:1021-34. (Pubitemid 20347464)
181. Coslett HB, Bowers D, Verfaellie M, Heilman KM. Frontal verbal amnesia. Phonological amnesia. Arch Neurol 1991;48:949-55.
182. Troyer AK, Moscovitch M, Winocur G, Alexander MP, Stuss D. Clustering and switching on verbal fluency: the effects of focal frontal- and temporal-lobe lesions. Neuropsychologia 1998;36:499-504. (Pubitemid 28342185)
183. Patterson K, Hodges JR. Deterioration of word meaning: implications for reading. Neuropsychologia 1992;30:1025-40. (Pubitemid 23023347)
184. Ober BA, Dronkers NF, Koss E, Delis DC, Friedland RP. Retrieval from semantic memory in Alzheimer-type dementia. J Clin Exp Neuropsychol 1986;8:75-92. (Pubitemid 16185036)
185. Coen RF, Maguire C, Swanwick GR, et al. Letter and category fluency in Alzheimer's disease: a prognostic indicator of progression? Dementia 1996;7:246-50. (Pubitemid 26278683)
186. Frith CD, Friston K, Liddle PF, Frackowiak RS. Willed action and the prefrontal cortex in man: a study with PET. Proc Biol Sci 1991;244:241-6.
187. Warkentin S, Passant U. Functional imaging of the frontal lobes in organic dementia. Regional cerebral blood flow findings in normals, in patients with frontotemporal dementia and in patients with Alzheimer's disease, performing a word fluency test. Dement Geriatr Cogn Disord 1997;8: 105-9. (Pubitemid 27173503)
188. Gaillard WD,Hertz-Pannier L, Mott SH, Barnett AS, LeBihan D, Theodore WH. Functional anatomy of cognitive development: fMRI of verbal fluency in children and adults. Neurology 2000;54:180-5. (Pubitemid 30038757)
189. Phelps EA, Hyder F, Blamire AM, Shulman RG. FMRI of the prefrontal cortex during overt verbal fluency. Neuroreport 1997;8:561-5. (Pubitemid 27180121)
190. Paulesu E, Goldacre B, Scifo P, et al. Functional heterogeneity of left inferior frontal cortex as revealed by fMRI. Neuroreport 1997;8:2011-7.
191. Roca M, Torrelva T, Lopez P, Cetkovich M, Clark L, Manes F. Executive functions in pathologic gamblers selected in an ecologic setting. Cogn Behav Neurol 2008;21:1-4. (Pubitemid 351355034)
192. Morris RG, Miotto EC, Feigenbaum JD, Bullock P, Polkey CE. The effect of goal-subgoal conflict on planning ability after frontal- and temporal-lobe lesions in humans. Neuropsychologia 1997;35:1147-57. (Pubitemid 27342967)
193. Morris RG, Ahmed S, Syed GM, Toone BK. Neural correlates of planning ability: frontal lobe activation during the Tower of London test. Neuropsychologia 1993;31:1367-78. (Pubitemid 24016959)
194. Baker SC, Rogers RD, Owen AM, et al. Neural systems engaged by planning: a PET study of the Tower of London task. Neuropsychologia 1996;34:515-26. (Pubitemid 26154489)
195. Owen AM, Doyon J, Petrides M, Evans AC. Planning and spatial working memory: a positron emission tomography study in humans. Eur J Neurosci 1996;8:353-64. (Pubitemid 26041333)
196. Dagher A, Owen AM, Boecker H, Brooks DJ. Mapping the network for planning: a correlational PET activation study with the Tower of London task. Brain 1999;122: 1973-87. (Pubitemid 29473868)
197. Owen AM, Doyon J, Dagher A, Sadikot A, Evans AC. Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain 1998;121:949-65. (Pubitemid 28220900)
198. Lazeron RH, Rombouts SA, MachielsenWC, et al. Visualizing brain activation during planning: the tower of London test adapted for functional MR imaging. AJNR Am J Neuroradiol 2000;21:1407-14.
199. van den Heuvel OA, Groenewegen HJ, Barkhof F, Lazeron RH, van Dyck R, Veltman DJ. Frontostriatal system in planning complexity: a parametric functional magnetic resonance version of Tower of London task. Neuroimage 2003;18: 367-74. (Pubitemid 36269146)
200. Cavedini P, Gorini A, Bellodi L. Understanding obsessive-compulsive disorder: focus on decision making. Neuropsychol Rev 2006;16:3-15. (Pubitemid 43954074)
201. Purcell R, Maruff P, Kyrios M, Pantelis C. Cognitive deficits in obsessive-compulsive disorder on tests of frontal-striatal function. Biol Psychiatry 1998;43:348-57. (Pubitemid 28137627)
202. Adolphs R, Tranel D, Denburg N. Impaired emotional declarative memory following unilateral amygdala damage. Learn Mem 2000;7:180-6. (Pubitemid 30407783)
203. Ernst M, Bolla K, Mouratidis M, et al. Decision-making in a risk-taking task: a PET study. Neuropsychopharmacology 2002;26:682-91. (Pubitemid 34260987)
204. Adinoff B, Devous MD Sr, Cooper DB, et al. Resting regional cerebral blood flow and gambling task performance in cocainedependent subjects and healthy comparison subjects. Am J Psychiatry 2003;160:1892-4. (Pubitemid 41103329)
205. Bolla KI, Eldreth DA, Matochik JA, Cadet JL. Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage 2005;26:480-92. (Pubitemid 40719826)
206. Dunn BD, Dalgleish T, Lawrence AD. The somatic marker hypothesis: a critical evaluation. Neurosci Biobehav Rev 2006;30:239-71. (Pubitemid 41821811)
207. Rogers RD, Andrews TC, Grasby PM, Brooks DJ, Robbins TW. Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans. J Cogn Neurosci 2000;12:142-62. (Pubitemid 30142790)
208. Petry NM, Casarella T. Excessive discounting of delayed rewards in substance abusers with gambling problems. Drug Alcohol Depend 1999;56:25-32. (Pubitemid 29295374)
209. Finn PR, Justus AN, Mazas C, Rorick L, Steinmetz JE. Constraint, alcoholism, and electrodermal response in aversive classical conditioning and mismatch novelty paradigms. Integr Physiol Behav Sci 2001;36:154-67. (Pubitemid 33642083)
210. Petry NM. Discounting of delayed rewards in substance abusers: relationship to antisocial personality disorder. Psychopharmacology (Berl) 2002;162:425-32. (Pubitemid 35001906)
211. Hommer D, Andreasen P, Rio D, et al. Effects of mchlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects. J Neurosci 1997;17:2796-806. (Pubitemid 27155013)
212. Volkow ND, Fowler JS, Wolf AP, et al. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 1991;148:621-6.
213. Petry NM. Substance abuse, pathological gambling, and impulsiveness. Drug Alcohol Depend 2001;63:29-38. (Pubitemid 32288732)
214. Linnet J, Rojskjaer S, Nygaard J,Maher BA. Episodic chasing in pathological gamblers using the Iowa gambling task. Scand J Psychol 2006;47:43-9. (Pubitemid 43428028)
215. Damasio AR. The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 1996;351:1413-20. (Pubitemid 127738807)
216. Bechara A, Damasio H. Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia 2002;40:1675-89. (Pubitemid 34462876)
217. Crone EA, Somsen RJ, Van Beek B, Van Der Molen MW. Heart rate and skin conductance analysis of antecendents and consequences of decision making. Psychophysiology 2004;41:531-40. (Pubitemid 38879769)
218. Hewig J, Kretschmer N, Trippe RH, et al. Hypersensitivity to reward in problem gamblers. Biol Psychiatry 2010;67:781-3.
219. Monterosso J, Ainslie G. The behavioral economics of will in recovery from addiction. Drug Alcohol Depend 2010;90 suppl 1:S100-11. (Pubitemid 46874781)
220. Boettiger CA, Mitchell JM, Tavares VC, et al. Immediate reward bias in humans: fronto-parietal networks and a role for the catechol-O-methyltransferase 158(Val/Val) genotype. J Neurosci 2007;27:14383-91.
221. Bickel WK, Odum AL, Madden GJ. Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl) 1999;146:447-54. (Pubitemid 29513285)
222. Vuchinich RE, Simpson CA. Hyperbolic temporal discounting in social drinkers and problem drinkers. Exp Clin Psychopharmacol 1998;6:292-305. (Pubitemid 28393947)
223. Petry NM. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates. J Abnorm Psychol 2001;110:482-7. (Pubitemid 32703085)
224. Madden GJ, Petry NM, Badger GJ, Bickel WK. Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards. Exp Clin Psychopharmacol 1997;5:256-62. (Pubitemid 27346450)
225. Kirby KN, Petry NM, Bickel WK. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen 1999;128:78-87.
226. Bickel WK, Marsch LA. Toward a behavioral economic understanding of drug dependence: delay discounting processes. Addiction 2001;96:73-86. (Pubitemid 32099341)
227. Dixon MR, Marley J, Jacobs EA. Delay discounting by pathological gamblers. J Appl Behav Anal 2003;36:449-58. (Pubitemid 38614996)
228. Kertzman S, Lowengrub K, Aizer A, Vainder M, Kotler M, Dannon PN. Go-no-go performance in pathological gamblers. Psychiatry Res 2008;161:1-10.
229. Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls. Brain Res Cogn Brain Res 2005;23:137-51. (Pubitemid 40417513)
230. Fuentes D, Tavares H, Artes R, Gorenstein C. Self-reported and neuropsychological measures of impulsivity in pathological gambling. J Int Neuropsychol Soc 2006;12:907-12. (Pubitemid 46415896)
231. van Den BrinkW. Evidence-based pharmacological treatment of substance use disorders and pathological gambling. Curr Drug Abuse Rev 2012;5:3-31.
232. Achab S, Khazaal Y. Psychopharmacological treatment in pathological gambling: a critical review. Curr Pharm Des 2011;17:1389-95.
233. Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C. A randomized doubleblind fluvoxamine/ placebo crossover trial in pathologic gambling. Biol Psychiatry 2000;47:813-7. (Pubitemid 30254054)
234. Blanco C, Petkova E, Ibáñez A, Saiz-Ruiz J. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 2002;14:9-15. (Pubitemid 34538827)
235. Dannon PN, Lowengrub K, Gonopolski Y, Musin E, Kotler M. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol 2005;28:6-10. (Pubitemid 40269711)
236. Zimmerman M, Breen RB, PosternakMA. An open-label study of citalopram in the treatment of pathological gambling. J Clin Psychiatry 2002;63:44-8. (Pubitemid 34113486)
237. BlackDW, ShawM, ForbushKT, Allen J. An open-label trial of escitalopram in the treatment of pathological gambling. Clin Neuropharmacol 2007;30:206-12. (Pubitemid 47356717)
238. Saiz-Ruiz J, Blanco C, Ibáñez A, et al. Sertraline treatment of pathological gambling: a pilot study. J Clin Psychiatry 2005;66:28-33.
239. Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli R. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 2002;63:501-7. (Pubitemid 34680358)
240. Dannon PN, Lowengrub K, Gonopolski Y, Musin E, Kotler M. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol 2005;28:6-10. (Pubitemid 40269711)
241. Black DW, Arndt S, Coryell WH, et al. Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. J Clin Psychopharmacol 2007;27:143-50. (Pubitemid 46594929)
242. Black DW, Shaw MC, Allen J. Extended release carbamazepine in the treatment of pathological gambling: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1191-4.
243. Kim SW, Grant JE. An open naltrexone treatment study in pathological gambling disorder. Int Clin Psychopharmacol 2001;16:285-9. (Pubitemid 32822448)
244. Kim SW, Grant JE, Adson DE, Shin YC. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001;49:914-21. (Pubitemid 32493813)
245. Pallanti S, Baldini Rossi N, Sood E, Hollander E. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial. J Clin Psychiatry 2002;63: 1034-9. (Pubitemid 35388064)
246. Grant JE, Kim SW, Hartman BK. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry 2008;69:783-9. (Pubitemid 351838687)
247. Grant JE, Chamberlain SR, Odlaug BL, Potenza MN, Kim SW. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology 2010;212:603-12.
248. Grant JE, Kim SW, Odlaug BL. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry 2007;62:652-7. (Pubitemid 47314380)
249. Goudriaan AE, Oosterlaan J, de Beurs E, Van den Brink W. Pathological gambling: a comprehensive review of biobehavioral findings. Neurosci Biobehav Rev 2004;28:123-41. (Pubitemid 38692361)